We are live on ! Find out more
CRDL

Cardiol Therapeutics
CRDL

41 hedge funds and large institutions have $8.69M invested in Cardiol Therapeutics in 2025 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more capital invested

Capital invested by funds: $7.8M → $8.69M (+$884K)

0.66% more ownership

Funds ownership: 8.49% → 9.15% (+0.66%)

8% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 12

15% less funds holding

Funds holding: 48 → 41 (-7)

36% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 14

Holders
41
Holders Change
-7
Holders Change %
-14.58%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
11
Reduced
12
Closed
14
Calls
$335K
Puts
–
Net Calls
+$335K
Net Calls Change
+$262K

Top Buyers

Rank Fund Capital Flow
1
TC
Tejara Capital
United Kingdom
+$2.62M
2
IA
Integrity Alliance
Iowa
+$456K
3
Morgan Stanley
Morgan Stanley
New York
+$197K
4
Two Sigma Investments
Two Sigma Investments
New York
+$183K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$116K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$485K
2
Marshall Wace
Marshall Wace
United Kingdom
-$411K
3
Bank of America
Bank of America
North Carolina
-$192K
4
VF
Virtu Financial
New York
-$154K
5
MI
MMCAP International
Cayman Islands
-$88.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$15.8K -$38.7K -36,941 -69%
WANY
27
Wealthspire Advisors (New York)
New York
$14.5K +$15.9K +15,151 New
MA
28
MONECO Advisors
Connecticut
$14.3K – – –
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$13K +$934 +892 +7%
IPW
30
Impact Partnership Wealth
Georgia
$10.3K +$11.4K +10,850 New
PSB
31
Piscataqua Savings Bank
New Hampshire
$10.3K – – –
Commonwealth Equity Services
32
Commonwealth Equity Services
Massachusetts
$10.2K +$136 +130 +1%
IAA
33
Independent Advisor Alliance
North Carolina
$9.54K – – –
TWC
34
TD Waterhouse Canada
Ontario, Canada
$6.87K +$314 +300 +4%
NA
35
NewEdge Advisors
Louisiana
$4.77K +$5.24K +5,000 New
VNA
36
Valley National Advisers
Pennsylvania
$4K – – –
National Bank of Canada
37
National Bank of Canada
Quebec, Canada
$1.61K +$141 +135 +9%
Osaic Holdings
38
Osaic Holdings
Arizona
$659 -$1.08K -1,032 -60%
DEM
39
Disciplined Equity Management
Florida
$605 +$524 +500 New
SS
40
SBI Securities
Japan
$453 -$1 -1 -0.2%
OC
41
Optima Capital
Oregon
$27 +$29 +28 New
Citadel Advisors
42
Citadel Advisors
Florida
– -$485K -463,462 Closed
VF
43
Virtu Financial
New York
– -$154K -144,062 Closed
HF
44
HRT Financial
New York
– -$52K -49,293 Closed
Envestnet Asset Management
45
Envestnet Asset Management
Illinois
– -$52.5K -48,629 Closed
BAAM
46
Baker Avenue Asset Management
California
– -$49K -45,402 Closed
AI
47
Atria Investments
North Carolina
– -$27.2K -25,436 Closed
TSS
48
Two Sigma Securities
New York
– -$22.1K -20,673 Closed
Cetera Investment Advisers
49
Cetera Investment Advisers
Illinois
– -$20.5K -19,013 Closed
BBA
50
Baader Bank Aktiengesellschaft
Germany
– -$6.66K -13,825 Closed
1
2
3

CRDL Hedge Fund Activity: Q4 2025 in Review

41 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Cardiol Therapeutics (CRDL) for Q4 2025, worth a combined $8.69M — up 11% from $7.8M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CRDL and 9 opened new positions — a net loss of 5 holders — while 12 trimmed existing stakes and 11 added.

The largest buyer was Tejara Capital, adding an estimated $2.62M. The largest seller was Citadel Advisors, exiting entirely with an estimated $485K sold.

  • 41 institutional investors held Cardiol Therapeutics (CRDL) as of Q4 2025, down from 48 in Q3 2025.
  • Funds reported $8.69M of Cardiol Therapeutics stock for Q4 2025, up 11% quarter-over-quarter.
  • 9 funds opened new Cardiol Therapeutics positions in Q4 2025 and 14 closed out, a net change of -5 holders.
  • The largest Cardiol Therapeutics buyer in Q4 2025 was Tejara Capital, an estimated $2.62M added.
  • The largest Cardiol Therapeutics seller in Q4 2025 was Citadel Advisors, an estimated $485K sold.

Based on aggregated 13F filings for Q4 2025.